Cosmos Health (NASDAQ:COSM) CEO Acquires $45,873.87 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 218,447 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was purchased at an average cost of $0.21 per share, for a total transaction of $45,873.87. Following the transaction, the chief executive officer owned 13,481,808 shares in the company, valued at approximately $2,831,179.68. The trade was a 1.65% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, June 10th, Grigorios Siokas bought 701,447 shares of Cosmos Health stock. The shares were acquired at an average price of $0.23 per share, for a total transaction of $161,332.81.

Cosmos Health Stock Performance

NASDAQ:COSM traded up $0.00 during trading hours on Friday, hitting $0.21. 4,182,989 shares of the company were exchanged, compared to its average volume of 1,232,909. The stock has a market capitalization of $12.91 million, a price-to-earnings ratio of -0.32 and a beta of 4.79. Cosmos Health Inc. has a 52-week low of $0.20 and a 52-week high of $1.32. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.08 and a quick ratio of 0.92. The company’s 50 day moving average price is $0.31 and its 200-day moving average price is $0.40.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). The business had revenue of $18.40 million for the quarter, compared to the consensus estimate of $17.93 million. Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%. As a group, research analysts forecast that Cosmos Health Inc. will post -0.06 earnings per share for the current year.

Institutional Trading of Cosmos Health

Hedge funds have recently added to or reduced their stakes in the company. XTX Topco Ltd boosted its holdings in Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after buying an additional 34,117 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Cosmos Health by 16.7% during the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock worth $124,000 after buying an additional 55,925 shares in the last quarter. Finally, Citadel Advisors LLC boosted its holdings in Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after buying an additional 128,776 shares in the last quarter. 12.61% of the stock is owned by hedge funds and other institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.